Penumbra Inc (PEN)
Financial leverage ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Total assets | US$ in thousands | 1,533,180 | 1,556,300 | 1,370,890 | 1,244,250 | 822,983 |
Total stockholders’ equity | US$ in thousands | 1,150,930 | 1,178,940 | 998,858 | 953,927 | 641,498 |
Financial leverage ratio | 1.33 | 1.32 | 1.37 | 1.30 | 1.28 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1,533,180K ÷ $1,150,930K
= 1.33
The financial leverage ratio of Penumbra Inc has been gradually increasing over the past five years. It was 1.28 as of December 31, 2020, and has risen to 1.30 by December 31, 2021. Subsequently, the ratio further increased to 1.37 by December 31, 2022. However, there was a slight decrease to 1.32 by December 31, 2023, followed by a marginal increase to 1.33 by December 31, 2024. Overall, the trend indicates a slight increase in the company's reliance on debt financing to support its operations and growth over the years analyzed.
Peer comparison
Dec 31, 2024
Company name
Symbol
Financial leverage ratio
Penumbra Inc
PEN
1.33
3M Company
MMM
10.38
Artivion Inc
AORT
2.86
Baxter International Inc
BAX
3.70
Becton Dickinson and Company
BDX
2.21
Boston Scientific Corp
BSX
1.81
DexCom Inc
DXCM
3.08
Embecta Corp
EMBC
—
Glaukos Corp
GKOS
1.27
Globus Medical
GMED
1.26
Haemonetics Corporation
HAE
2.29